Monica Forbes
Corporate Officer/Principal en APOGEE THERAPEUTICS, INC. .
Fortuna: 57 392 $ al 31/03/2024
Perfil
Monica Forbes is a Senior Vice President-Finance at Apogee Therapeutics, Inc. She was previously the Chief Financial Officer & Vice President at Orexigen Therapeutics, Inc. from 2014 to 2018, and at Nalpropion Pharmaceuticals, Inc. from 2018 to 2019.
From 2019 to present, she held the position of Chief Financial Officer & Vice President at Sesen Bio, Inc. Ms. Forbes completed her undergraduate degree at San Diego State University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/03/2023 | 25 283 ( 0.06% ) | 57 392 $ | 31/03/2024 |
Cargos activos de Monica Forbes
| Empresas | Cargo | Inicio |
|---|---|---|
| APOGEE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2023 |
Antiguos cargos conocidos de Monica Forbes.
| Empresas | Cargo | Fin |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Director of Finance/CFO | 07/03/2023 |
Nalpropion Pharmaceuticals, Inc.
 Nalpropion Pharmaceuticals, Inc. Managed Health CareHealth Services Nalpropion Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the treatment of weight loss. Its products include CONTRAVE, analtrexone HCl & bupropion HCl extended release and Mysimba, a naltrexone HCl/ bupropion HCl prolonged release. The company is headquartered in Morristown, NJ. | Director of Finance/CFO | 01/04/2019 |
| OREXIGEN THERAPEUTICS, INC. | Director of Finance/CFO | 27/07/2018 |
Formación de Monica Forbes.
| San Diego State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| APOGEE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Nalpropion Pharmaceuticals, Inc.
Nalpropion Pharmaceuticals, Inc. Managed Health CareHealth Services Nalpropion Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the treatment of weight loss. Its products include CONTRAVE, analtrexone HCl & bupropion HCl extended release and Mysimba, a naltrexone HCl/ bupropion HCl prolonged release. The company is headquartered in Morristown, NJ. | Health Services |
- Bolsa de valores
- Insiders
- Monica Forbes
